Various Local Hemostatic Agents with Different Modes of Action; an in vivo Comparative Randomized Vascular Surgical Experimental Study

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 3, 2007, Pages 363-370

  Bjorses K ^a   Holst, J ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bovine thrombin; Local hemostasis; Microporous polysaccharide hemispheres; Recombinant FVIIa

Indexed keywords

COLLAGEN; FLOSEAL; HEMOSTATIC AGENT; POLYSACCHARIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; TRAUMADEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD PRESSURE; CAROTID ARTERY LIGATION; COMBINATION CHEMOTHERAPY; COMMON CAROTID ARTERY; COMPRESSION THERAPY; CONTROLLED STUDY; DRUG MECHANISM; EXPERIMENTAL STUDY; HEMOSTASIS; HEPARINIZATION; IN VIVO STUDY; MALE; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; VASCULAR SURGERY;

ANIMALS; FACTOR VII; HEMOSTASIS, SURGICAL; HEMOSTATICS; PROTHROMBIN TIME; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; THROMBIN; VASCULAR SURGICAL PROCEDURES;

EID: 33846686789     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.10.011     Document Type: Article

References (24)

1. Jackson M.R., MacPhee M.J., Drohan W.N., and Alving B.M. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis 7 (1996) 737-746
2. Hedner U., and Erhardtsen E. Potential role of rFVIIa in transfusion medicine. Transfusion 42 (2002) 114-124
3. Holcomb J.B. Use of recombinant activated FVII to treat the aquired coagulopathy of trauma. J Trauma 58 (2005) 1298-1303
4. Tuthill D.D., Bayer V., Gallagher A.M., Drohan W.N., and MacPhee M.J. Assesment of topical hemostats in a renal hemorrhage model in heparinized rats. J Surg Res 95 (2001) 126-132
5. Jackson M.R., Taher M.M., Burge J.R., Krishnamurti C., Reid T.J., and Alving B.M. Hemostatic efficacy of a fibrin sealant dressing in an animal model of kidney injury. J Trauma 45 (1998) 662-665
6. Petratos P.B., Ito K., Felsen D., and Poppas D. Crosslinked matrix tissue sealant protects against mortality and hemorrhage in an acute renal injury model in heparinized rats. J Urol 167 (2002) 2222-2224
7. Murat F.J.L., Ereth M.H., Dong Y., Piedra M.P., and Gettman M.T. Evaluation of microporous polysaccaride hemospheres as a novel hemostatic agent in open partial nephrectomy: favorable experimental results in the porcine model. J Urol 172 (2004) 1119-1122
8. Pusateri A.E., Modrow H.E., Harris R.A., Holcomb J.B., Hess J.R., Mosebar R.H., et al. Advanced hemostatic dressing development program: animal model selection criteria and reults of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in swine. J Trauma 55 (2003) 518-526
9. Alam H.B., Uy G.B., Miller D., Koustova E., Hancock T., Inocencio R., et al. Comparative analyses of hemostatic agents in a swine model of lethal groin injury. J Trauma 54 (2003) 1077-1082
10. Kheirabadi B.S., Field-Ridley A., Pearson R., MacPhee M., Drohan W., and Tuthill D. Comparative study of the common topical hemostatic agents with fibrin sealant in a rabbit aortic anastomosis model. J Surg Res 106 (2002) 99-107
11. Ünlü Y., Vural U., Kocak H., Ceviz M., and Akbulut O. Comparison of the topical haemostatic agents for the prevention of suture hole bleeding. An Experimental Study. Eur J Vasc Endovasc Surg 23 (2002) 441-444
12. Malm K., Dahlbäck B., and Arnljots B. Low-Molecular-Weight Heparin (Dalteparin) Effectively prevents thrombosis in a rat model of deep arterial injury. Plast Reconstr Surg 111 (2003) 1659-1666
13. Söderström T., Hedner U., and Arnljots B. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury. J Vasc Surg 33 (2001) 1072-1079
14. Weaver F.A., Hood D.B., Zalita M., and Messina L. Badduke B. Gelatin-thrombin based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 16 (2002) 286-293
15. Schenk W.G., Burks S.G., Gagne P.J., Kagan S.A., Lawson J.H., and Spotnitz W.D. Fibrin sealant improves hemostasis in peripheral vascualar surgery: a randomized prospective trial. Ann Surg 237 (2003) 871-876
16. Glickman M., Gheissari A., Money S., Martin J., and Ballard J.L. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin. Arch Surg 137 (2002) 326-331
17. Taylor L.M., Mueller-Velten G., Koslow A., Hunter G., Naslund T., Kline R., et al. Prospective randomized multicenter trial of fibrin sealant versus thrombin soaked gelatin sponge for suture- or needle hole bleeding from polytetrafluoroethylene femoral artery grafts. J Vasc Surg 38 (2003) 766-771
18. Oz M.C., Cosgrove D.M., Badduke B.R., Hill D.J., Flannery M.R., Palumbo R., et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 69 (2000) 1376-1382
19. Renkens K.L., Payner T.D., Leipzig T.J., Feuer H., Morone M.A., Koers J.M., et al. A multicenter, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine 26 (2001) 1645-1650
20. Stricker R.B., Lanc P.K., Leffert J.D., Rodgers G.M., Shurnan M.A., and Corash L. Development of antithrombin antibodies following surgery in patients with prostethic cardiac valves. Blood 72 (1988) 1375-1380
21. Rapaport S.I., Zivelin A., Minow R.A., Hunter C.S., and Donelly K. Clinical significance of autoantibodies to bovine thrombin and factor V after surgical use of bovine thrombin. Am J Clin Pathol 97 (1992) 84-91
22. Streiff M.B., and Ness P.M. Aquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 42 (2002) 18-26
23. Boffard K.D., Riou B., Warren B., Choong P.I.T., Rizoli S., Rossaint R., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-18
24. Manning B.J., Hynes N., Courtney D.F., and Sultan S. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. Eur J Vasc Endovasc Surg 30 (2005) 525-527